SCHEMBL7359019

SCHEMBL7359019

[CH2]c1cccc(NCCCC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
HTT P42858 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
F2R P25116 2/20 0.47
ALDH1A1 P00352 3/20 0.42
ABL1 P00519 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
KCNH3 Q9ULD8 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
AR P10275 1/20 0.38
TLR8 Q9NR97 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27600912 0.93 ABL1 (0.50) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL7327076 0.90 MAPT (0.55) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL8667014 0.86 F2R (0.56) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL2459476 0.81 DRD3 (0.47) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL3662823 0.80 ABL1 (0.54) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL2642572 0.80 MAPT (0.47) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL31519377 0.79 MAPT (0.74) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL3440754 0.79 MAPT (0.74) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL27642277 0.79 F2R (0.48) MAPTHTTCYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL28323586 0.79 MAPT (0.45) MAPTHTTCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE37781-E1 VIRICIDES, PROTEASE INHIBITOR DUPONT PHARMACEUTICALS COMPANY 2002-07-02 US claimed
EP-0815108-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-07 EP claimed
US-5683999-A Cyclic urea HIV protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-11-04 US claimed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US claimed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO claimed
EP-0815108-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-07 EP disclosed
US-5683999-A Cyclic urea HIV protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-11-04 US disclosed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO disclosed